Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 8: 50th year of the DMDG
4,551
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Potential application of mass spectrometry imaging in pharmacokinetic studies

&
Pages 811-827 | Received 29 Jul 2022, Accepted 29 Aug 2022, Published online: 20 Dec 2022

References

  • Abbas I, Noun M, Touboul D, Sahali D, Brunelle A, Ollero M. 2019. Kidney lipidomics by mass spectrometry imaging: a focus on the glomerulus. IJMS. 20(7):1623.
  • Abdelmoula WM, Regan MS, Lopez BGC, Randall EC, Lawler S, Mladek AC, Nowicki MO, Marin BM, Agar JN, Swanson KR, et al. 2019. Automatic 3D nonlinear registration of mass spectrometry imaging and magnetic resonance imaging data. Anal Chem. 91(9):6206–6216.
  • Ait-Belkacem R, Bol V, Hamm G, Schramme F, Van Den Eynde B, Poncelet L, Pamelard F, Stauber J, Gomes B. 2017. Microenvironment tumor metabolic interactions highlighted by qMSI: application to the tryptophan-kynurenine pathway in immuno-oncology. SLAS Discov. 22(10):1182–1192.
  • Asslan M, Lauzon N, Beus M, Maysinger D, Rousseau S. 2021. Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism. Anal Bioanal Chem. 413(20):5135–5146.
  • Atkinson SJ, Loadman PM, Sutton C, Patterson LH, Clench MR. 2007. Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom. 21(7):1271–1276.
  • Awad H, Khamis MM, El-Aneed A. 2015. Mass spectrometry, review of the basics: ionization. Appl Spectrosc Rev. 50(2):158–175.
  • Bäckström E, Hamm G, Nilsson A, Fihn B-M, Strittmatter N, Andrén P, Goodwin RJA, Fridén M. 2018. Uncovering the regional localization of inhaled salmeterol retention in the lung. Drug Deliv. 25(1):838–845.
  • Balog J, Sasi-Szabó L, Kinross J, Lewis MR, Muirhead LJ, Veselkov K, Mirnezami R, Dezső B, Damjanovich L, Darzi A, et al. 2013. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci Transl Med. 5(194):194ra93.
  • Barry JA, Ait-Belkacem R, Hardesty WM, Benakli L, Andonian C, Licea-Perez H, Stauber J, Castellino S. 2019. Multicenter validation study of quantitative imaging mass spectrometry. Anal Chem. 91(9):6266–6274.
  • Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé J-P, Heditsian D, Swigart-Brown L, et al. 2017. Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors. Breast Cancer Res. 19(1):107.
  • Bartels B, Kulkarni P, Danz N, Böcker S, Saluz HP, Svatoš A. 2017. Mapping metabolites from rough terrain: laser ablation electrospray ionization on non-flat samples. RSC Adv. 7(15):9045–9050.
  • Bednařík A, Bölsker S, Soltwisch J, Dreisewerd K. 2018. An on-tissue Paternò-Büchi reaction for localization of carbon-carbon double bonds in phospholipids and glycolipids by matrix-assisted laser-desorption-ionization mass-spectrometry imaging. Angew Chem Int Ed Engl. 57(37):12092–12096.
  • Bergman H-M, Lundin E, Andersson M, Lanekoff I. 2016. Quantitative mass spectrometry imaging of small-molecule neurotransmitters in rat brain tissue sections using nanospray desorption electrospray ionization. Analyst. 141(12):3686–3695.
  • Boskamp T, Casadonte R, Hauberg-Lotte L, Deininger S, Kriegsmann J, Maass P. 2021. Cross-normalization of MALDI mass spectrometry imaging data improves site-to-site reproducibility. Anal Chem. 93(30):10584–10592.
  • Brater DC. 2002. Measurement of renal function during drug development. Br J Clin Pharmacol. 54(1):87–95.
  • Brignole-Baudouin F, Desbenoit N, Hamm G, Liang H, Both JP, Brunelle A, Fournier I, Guerineau V, Legouffe R, Stauber J, et al. 2012. A New safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits. PLoS ONE. 7(11):e50180.
  • Buchberger AR, DeLaney K, Johnson J, Li L. 2018. Mass spectrometry imaging: a review of emerging advancements and future insights. Anal Chem. 90(1):240–265.
  • Buck A, Halbritter S, Späth C, Feuchtinger A, Aichler M, Zitzelsberger H, Janssen KP, Walch A. 2015. Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Anal Bioanal Chem. 407(8):2107–2116.
  • Burnum KE, Frappier SL, Caprioli RM. 2008. Matrix-assisted laser desorption/ionization imaging mass spectrometry for the investigation of proteins and peptides. Annu Rev Anal Chem. 1:689–705.
  • Casadonte R, Caprioli RM. 2011. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat Protoc. 6(11):1695–1709.
  • Castellino S, Groseclose MR, Sigafoos J, Wagner D, De Serres M, Polli JW, Romach E, Myer J, Hamilton B. 2013. Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity. Chem Res Toxicol. 26(2):241–251.
  • Castellino S, Groseclose MR, Wagner D. 2011. MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. Bioanalysis. 3(21):2427–2441.
  • Chen Y, Wang T, Xie P, Song Y, Wang J, Cai Z. 2021. Mass spectrometry imaging revealed alterations of lipid metabolites in multicellular tumor spheroids in response to hydroxychloroquine. Anal Chim Acta. 1184:339011.
  • Chughtai K, Heeren RMA. 2010. Mass spectrometric imaging for biomedical tissue analysis. Chem Rev. 110(5):3237–3277.
  • Cobice DF, Goodwin RJA, Andren PE, Nilsson A, Mackay CL, Andrew R. 2015. Future technology insight: mass spectrometry imaging as a tool in drug research and development. Br J Pharmacol. 172(13):3266–3283.
  • Deininger S-O, Cornett DS, Paape R, Becker M, Pineau C, Rauser S, Walch A, Wolski E. 2011. Normalization in MALDI-TOF imaging datasets of proteins: practical considerations. Anal Bioanal Chem. 401(1):167–181.
  • Dekker TJA, Balluff BD, Jones EA, Schöne CD, Schmitt M, Aubele M, Kroep JR, Smit V, Tollenaar RAEM, Mesker WE, et al. 2014. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. J Proteome Res. 13(11):4730–4738.
  • Desbenoit N, Walch A, Spengler B, Brunelle A, Römpp A. 2018. Correlative mass spectrometry imaging, applying time-of-flight secondary ion mass spectrometry and atmospheric pressure matrix-assisted laser desorption/ionization to a single tissue section. Rapid Commun Mass Spectrom. 32(2):159–166.
  • Dexter A, Steven RT, Patel A, Dailey LA, Taylor AJ, Ball D, Klapwijk J, Forbes B, Page CP, Bunch J. 2019. Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis. Anal Bioanal Chem. 411(30):8023–8032.
  • Drexler DM, Garrett TJ, Cantone JL, Diters RW, Mitroka JG, Prieto Conaway MC, Adams SP, Yost RA, Sanders M. 2007. Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. J Pharmacol Toxicol Methods. 55(3):279–288.
  • Ellis SR, Paine MRL, Eijkel GB, Pauling JK, Husen P, Jervelund MW, Hermansson M, Ejsing CS, Heeren RMA. 2018. Automated, parallel mass spectrometry imaging and structural identification of lipids. Nat Methods. 15(7):515–518.
  • Feenstra AD, Dueñas ME, Lee YJ. 2017. Five micron high resolution MALDI mass spectrometry imaging with simple, interchangeable, multi-resolution optical system. J Am Soc Mass Spectrom. 28(3):434–442.
  • Föll MC, Moritz L, Wollmann T, Stillger MN, Vockert N, Werner M, Bronsert P, Rohr K, Grüning BA, Schilling O. 2019. Accessible and reproducible mass spectrometry imaging data analysis in Galaxy. GigaScience. 8(12):giz143.
  • Fonville JM, Carter C, Cloarec O, Nicholson JK, Lindon JC, Bunch J, Holmes E. 2012. Robust data processing and normalization strategy for MALDI mass spectrometric imaging. Anal Chem. 84(3):1310–1319.
  • Fuso Nerini I, Morosi L, Zucchetti M, Ballerini A, Giavazzi R, D'Incalci M. 2014. Intratumor heterogeneity and its impact on drug distribution and sensitivity. Clin Pharmacol Ther. 96(2):224–238.
  • Gilmore IS, Heiles S, Pieterse CL. 2019. Metabolic imaging at the single-cell scale: recent advances in mass spectrometry imaging. Annu Rev Anal Chem. 12(1):201–224.
  • Goodwin RJA. 2012. Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences. J Proteomics. 75(16):4893–4911.
  • Goodwin RJA, Bunch J, McGinnity DF. 2017. Mass spectrometry imaging in oncology drug discovery. 1st ed. Amsterdam: Elsevier Inc.
  • Goodwin RJA, Nilsson A, Mackay CL, Swales JG, Johansson MK, Billger M, Andrén PE, Iverson SL. 2016. Exemplifying the screening power of mass spectrometry imaging over label-based technologies for simultaneous monitoring of drug and metabolite distributions in tissue sections. J Biomol Screening. 21(2):187–193.
  • Goodwin RJA, Takats Z, Bunch J. 2020. A critical and concise review of mass spectrometry applied to imaging in drug discovery. SLAS Discov. 25(9):963–976.
  • Granborg JR, Handler AM, Janfelt C. 2022. Mass spectrometry imaging in drug distribution and drug metabolism studies – principles, applications and perspectives. TrAC. 146:116482.
  • Grélard F, Legland D, Fanuel M, Arnaud B, Foucat L, Rogniaux H. 2021. Esmraldi: efficient methods for the fusion of mass spectrometry and magnetic resonance images. BMC Bioinformatics. 22(1):56.
  • Groseclose MR, Laffan SB, Frazier KS, Hughes-Earle A, Castellino S. 2015. Imaging MS in toxicology: an investigation of juvenile rat nephrotoxicity associated with dabrafenib administration. J Am Soc Mass Spectrom. 26(6):887–898.
  • Grove KJ, Hoque S, Rudewicz PJ. 2019. Investigation of amodiaquine localization in liver lobules using matrix-assisted laser desorption/ionization imaging mass spectrometry. Rapid Commun Mass Spectrom. 33(3):252–258.
  • Hamm G, Bonnel D, Legouffe R, Pamelard F, Delbos J-M, Bouzom F, Stauber J. 2012. Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor. J Proteomics. 75(16):4952–4961.
  • Hamm GR, Bäckström E, Brülls M, Nilsson A, Strittmatter N, Andrén PE, Grime K, Fridén M, Goodwin RJA. 2020. Revealing the regional localization and differential lung retention of inhaled compounds by mass spectrometry imaging. J Aerosol Med Pulm Drug Deliv. 33(1):43–53.
  • Hansen RL, Lee YJ. 2017. Overlapping MALDI-mass spectrometry imaging for in-parallel MS and MS/MS data acquisition without sacrificing spatial resolution. J Am Soc Mass Spectrom. 28(9):1910–1918.
  • Harvey A, Cole LM, Day R, Bartlett M, Warwick J, Bojar R, Smith D, Cross N, Clench MR. 2016. MALDI-MSI for the analysis of a 3D tissue-engineered psoriatic skin model. Proteomics. 16(11–12):1718–1725.
  • He J, Huang L, Tian R, Li T, Sun C, Song X, Lv Y, Luo Z, Li X, Abliz Z. 2018. MassImager: a software for interactive and in-depth analysis of mass spectrometry imaging data. Anal Chim Acta. 1015:50–57.
  • He Q, Sun C, Liu J, Pan Y. 2021. MALDI-MSI analysis of cancer drugs: significance, advances, and applications. TrAC. 136:116183.
  • Hernandez-Aya LF, Gonzalez-Angulo AM. 2013. Adjuvant systemic therapies in breast cancer. Surg Clin North Am. 93(2):473–491.
  • Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181(2):271–280.e8.
  • Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, Kato T, Lee RE, Yount BL, Mascenik TM, et al. 2020. SARS-CoV-2 Reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 182(2):429–446.e14.
  • Hsieh Y, Casale R, Fukuda E, Chen J, Knemeyer I, Wingate J, Morrison R, Korfmacher W. 2006. Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun Mass Spectrom. 20(6):965–972.
  • Hsieh Y, Chen J, Knemeyer I, Crossman L, Korfmacher W. 2008. Visualization of first-pass drug metabolism of terfenadine by MALDIImaging mass spectrometry. Drug Metab Lett. 2(1):1–4.
  • Huizing LRS, McDuffie J, Cuyckens F, Van Heerden M, Koudriakova T, Heeren RMA, Vreeken RJ. 2021. Quantitative mass spectrometry imaging to study drug distribution in the intestine following oral dosing. Anal Chem. 93(4):2144–2151.
  • Hwang TJ, Carpenter D, Lauffenburger JC, Wang B, Franklin JM, Kesselheim AS. 2016. Failure of investigational drugs in late-stage clinical development and publication of trial results. JAMA Intern Med. 176(12):1826.
  • Ifa DR, Wu C, Ouyang Z, Cooks RG. 2010. Desorption electrospray ionization and other ambient ionization methods: current progress and preview. Analyst. 135(4):669–681.
  • Ishii Y, Nakamura K, Mitsumoto T, Takimoto N, Namiki M, Takasu S, Ogawa K. 2022. Visualization of the distribution of anthraquinone components from madder roots in rat kidneys by desorption electrospray ionization-time-of-flight mass spectrometry imaging. Food Chem Toxicol. 161:112851.
  • Jiang H, Gao S, Hu G, He J, Jin H. 2021. Innovation in drug toxicology: application of mass spectrometry imaging technology. Toxicology. 464:153000.
  • Kavan S, Kruse TA, Vogsen M, Hildebrandt MG, Thomassen M. 2022. Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review. Cancer Metastasis Rev. 41(2):433–446.
  • Kompauer M, Heiles S, Spengler B. 2017a. Atmospheric pressure MALDI mass spectrometry imaging of tissues and cells at 1.4-μm lateral resolution. Nat Methods. 14(1):90–96.
  • Kompauer M, Heiles S, Spengler B. 2017b. Autofocusing MALDI mass spectrometry imaging of tissue sections and 3D chemical topography of nonflat surfaces. Nat Methods. 14(12):1156–1158.
  • Kreye F, Hamm G, Karrout Y, Legouffe R, Bonnel D, Siepmann F, Siepmann J. 2012. MALDI-TOF MS imaging of controlled release implants. J Control Release. 161(1):98–108.
  • Lamont L, Hadavi D, Viehmann B, Flinders B, Heeren RMA, Vreeken RJ, Porta Siegel T. 2021. Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison. Anal Bioanal Chem. 413(10):2779–2791.
  • Lennernäs H. 1998. Human intestinal permeability. J Pharm Sci. 87(4):403–410.
  • Li Y, Cao F, Li M, Li P, Yu Y, Xiang L, Xu T, Lei J, Tai YY, Zhu J, et al. 2018. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. J Exp Clin Cancer Res. 37(1):16.
  • Lim HS, Im JS, Cho JY, Bae KS, Klein TA, Yeom JS, Kim TS, Choi JS, Jang IJ, Park JW. 2009. Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by plasmodium vivax. Antimicrob Agents Chemother. 53(4):1468–1475.
  • Lin YC, Lin JF, Wen SI, Yang SC, Tsai TF, Chen HE, Chou KY, Hwang TIS. 2017. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J Med Sci. 33(5):215–223.
  • Lindros KO. 1997. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol. 28(2):191–196.
  • Liu X, Hummon AB. 2015. Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell cultures. Anal Chem. 87(19):9508–9519.
  • Liu X, Ide JL, Norton I, Marchionni MA, Ebling MC, Wang LY, Davis E, Sauvageot CM, Kesari S, Kellersberger KA, et al. 2013. Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep. 3:2859.
  • Liu X, Weaver EM, Hummon AB. 2013. Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry. Anal Chem. 85(13):6295–6302.
  • López-Fernández H, de S. Pessôa G, Arruda MAZ, Capelo-Martínez JL, Fdez-Riverola F, Glez-Peña D, Reboiro-Jato M. 2016. LA-iMageS: a software for elemental distribution bioimaging using LA–ICP–MS data. J Cheminform. 8:65.
  • Lovitt CJ, Shelper TB, Avery VM. 2018. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer. 18(1):11.
  • Lukowski JK, Weaver EM, Hummon AB. 2017. Analyzing liposomal drug delivery systems in three-dimensional cell culture models using MALDI imaging mass spectrometry. Anal Chem. 89(16):8453–8458.
  • Ly A, Longuespée R, Casadonte R, Wandernoth P, Schwamborn K, Bollwein C, Marsching C, Kriegsmann K, Hopf C, Weichert W, et al. 2019. Site‐to‐site reproducibility and spatial resolution in MALDI–MSI of peptides from formalin‐fixed paraffin‐embedded samples. Prot Clin Appl. 13(1):1800029.
  • Matsumoto T, Kushida H, Matsushita S, Oyama Y, Suda T, Watanabe J, Kase Y, Setou M. 2017. Distribution analysis via mass spectrometry imaging of ephedrine in the lungs of rats orally administered the Japanese Kampo Medicine Maoto. Sci Rep. 7:44098.
  • McDonnell LA, Römpp A, Balluff B, Heeren RMA, Albar JP, Andrén PE, Corthals GL, Walch A, Stoeckli M. 2015. Discussion point: reporting guidelines for mass spectrometry imaging. Anal Bioanal Chem. 407(8):2035–2045.
  • Meistermann H, Norris JL, Aerni HR, Cornett DS, Friedlein A, Erskine AR, Augustin A, Vera Mudry MCD, Ruepp S, Suter L, et al. 2006. Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat. Mol Cell Proteom. 5(10):1876–1886.
  • Minchinton AI, Tannock IF. 2006. Drug penetration in solid tumours. Nat Rev Cancer. 6(8):583–592.
  • Miyamoto S, Hsu CC, Hamm G, Darshi M, Diamond-Stanic M, Declèves AE, Slater L, Pennathur S, Stauber J, Dorrestein PC, et al. 2016. Mass spectrometry imaging reveals elevated glomerular ATP/AMP in diabetes/obesity and identifies sphingomyelin as a possible mediator. EBioMedicine. 7:121–134. The Authors.
  • Morikawa-Ichinose T, Fujimura Y, Murayama F, Yamazaki Y, Yamamoto T, Wariishi H, Miura D. 2019. Improvement of sensitivity and reproducibility for imaging of endogenous metabolites by matrix-assisted laser desorption/ionization-mass spectrometry. J Am Soc Mass Spectrom. 30(8):1512–1520.
  • Munteanu B, Meyer B, Von Reitzenstein C, Burgermeister E, Bog S, Pahl A, Ebert MP, Hopf C. 2014. Label-free in situ monitoring of histone deacetylase drug target engagement by matrix-assisted laser desorption ionization-mass spectrometry biotyping and imaging. Anal Chem. 86(10):4642–4647.
  • Niehaus M, Schnapp A, Koch A, Soltwisch J, Dreisewerd K. 2017. New insights into the wavelength dependence of MALDI mass spectrometry. Anal Chem. 89(14):7734–7741.
  • Nilsson A, Goodwin RJA, Shariatgorji M, Vallianatou T, Webborn PJH, Andrén PE. 2015. Mass spectrometry imaging in drug development. Anal Chem. 87(3):1437–1455.
  • Nilsson A, Goodwin RJA, Swales JG, Gallagher R, Shankaran H, Sathe A, Pradeepan S, Xue A, Keirstead N, Sasaki JC, et al. 2015. Investigating nephrotoxicity of polymyxin derivatives by mapping renal distribution using mass spectrometry imaging. Chem Res Toxicol. 28(9):1823–1830.
  • Nilsson A, Peric A, Strimfors M, Goodwin RJA, Hayes MA, Andrén PE, Hilgendorf C. 2017. Mass spectrometry imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis. Sci Rep. 7(1):10.
  • Norris JL, Cornett DS, Mobley JA, Andersson M, Seeley EH, Chaurand P, Caprioli RM. 2007. Processing MALDI mass spectra to improve mass spectral direct tissue analysis. Int J Mass Spectrom. 260(2–3):212–221.
  • Nwabufo C, Krol E. 2019. Unraveling the metabolic fate of potential therapeutic dimer compounds for Parkinson’s disease. Drug Metab Pharmacokinet. 34(1):S59–S60.
  • Nwabufo CK. 2021. Introduction to the mini special issue on next generation drug discovery and development: rethinking translational pharmacology for accelerated drug development. Drug Metab Rev. 53(2):171–172.
  • Nwabufo CK. 2022. Relevance of ABC transporters in drug development. CDM. 23(6):434–446.
  • Nwabufo CK, Aigbogun OP. 2022. Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease. J Neurol. 1–25.
  • Nwabufo CK, El-Aneed A, Krol ES. 2019. Tandem mass spectrometric analysis of novel caffeine scaffold-based bifunctional compounds for Parkinson’s disease. Rapid Commun Mass Spectrom. 33(23):1792–1803.
  • Oliver RE, Jones AF, Rowland M. 1998. What surface of the intestinal epithelium is effectively available to permeating drugs. J Pharm Sci. 87(5):634–639.
  • Paine MRL, Poad BLJ, Eijkel GB, Marshall DL, Blanksby SJ, Heeren RMA, Ellis SR. 2018. Mass spectrometry imaging with isomeric resolution enabled by ozone‐induced dissociation. Angew Chem Int Ed Engl. 57(33):10530–10534.
  • Palmer A, Phapale P, Chernyavsky I, Lavigne R, Fay D, Tarasov A, Kovalev V, Fuchser J, Nikolenko S, Pineau C, et al. 2017. FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry. Nat Methods. 14(1):57–60.
  • Ponticelli C, Moroni G. 2017. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf. 16(3):411–419. Taylor & Francis.
  • Porta T, Lesur A, Varesio E, Hopfgartner G. 2015. Quantification in MALDI-MS imaging: what can we learn from MALDI-selected reaction monitoring and what can we expect for imaging? Anal Bioanal Chem. 407(8):2177–2187.
  • Pozebon D, Scheffler GL, Dressler VL, Nunes MAG. 2014. Review of the applications of laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) to the analysis of biological samples. J Anal at Spectrom. 29(12):2204–2228.
  • Prentice BM, Chumbley CW, Caprioli RM. 2015. High-speed MALDI MS/MS imaging mass spectrometry using continuous raster sampling: high-speed TOF/TOF imaging. J Mass Spectrom. 50(4):703–710.
  • Prideaux B, Stoeckli M. 2012. Mass spectrometry imaging for drug distribution studies. J Proteomics. 75(16):4999–5013.
  • Pritchard JF, Jurima-Romet M, Reimer MLJ, Mortimer E, Rolfe B, Cayen MN. 2003. Making better drugs: decision gates in non-clinical drug development. Nat Rev Drug Discov. 2(7):542–553.
  • Ràfols P, Heijs B, del Castillo E, Yanes O, McDonnell LA, Brezmes J, Pérez-Taboada I, Vallejo M, García-Altares M, Correig X. 2020. rMSIproc: an R package for mass spectrometry imaging data processing. Bioinformatics. 36(11):3618–3619.
  • Ràfols P, Torres S, Ramírez N, del Castillo E, Yanes O, Brezmes J, Correig X. 2017. rMSI: an R package for MS imaging data handling and visualization. Bioinformatics. 33(15):2427–2428.
  • Rahim R, Strobl JS. 2009. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Anticancer Drugs. 20(8):736–745.
  • Raj GM, Raveendran R, editors. 2019. Introduction to basics of pharmacology and toxicology. Volume 1: general and molecular pharmacology: principles of drug action. Singapore: Springer.
  • Rendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, Park J, Foox J, Hether T, Warren S, et al. 2021. The spatial landscape of lung pathology during COVID-19 progression. Nature. 593(7860):564–569.
  • Römpp A, Both J-P, Brunelle A, Heeren RMA, Laprévote O, Prideaux B, Seyer A, Spengler B, Stoeckli M, Smith DF. 2015. Mass spectrometry imaging of biological tissue: an approach for multicenter studies. Anal Bioanal Chem. 407(8):2329–2335.
  • Russell LE, Zhou Y, Almousa AA, Sodhi JK, Nwabufo CK, Lauschke VM. 2021. Pharmacogenomics in the era of next generation sequencing–from byte to bedside. Drug Metab Rev. 53(2):253–278.
  • Saggar JK, Yu M, Tan Q, Tannock IF. 2013. The tumor microenvironment and strategies to improve drug distribution. Front Oncol. 3 (JUN):1–7.
  • Shariatgorji M, Nilsson A, Goodwin RJA, Källback P, Schintu N, Zhang X, Crossman AR, Bezard E, Svenningsson P, Andren PE. 2014. Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron. 84(4):697–707.
  • Shariatgorji M, Strittmatter N, Nilsson A, Källback P, Alvarsson A, Zhang X, Vallianatou T, Svenningsson P, Goodwin RJA, Andren PE. 2016. Simultaneous imaging of multiple neurotransmitters and neuroactive substances in the brain by desorption electrospray ionization mass spectrometry. Neuroimage. 136:129–138.
  • Sheraz Née Rabbani S, Berrueta Razo I, Kohn T, Lockyer NP, Vickerman JC. 2015. Enhancing Ion yields in time-of-flight-secondary ion mass spectrometry: a comparative study of argon and water cluster primary beams. Anal Chem. 87(4):2367–2374.
  • Soltwisch J, Jaskolla TW, Hillenkamp F, Karas M, Dreisewerd K. 2012. Ion yields in UV-MALDI mass spectrometry as a function of excitation laser wavelength and optical and physico-chemical properties of classical and halogen-substituted MALDI matrixes. Anal Chem. 84(15):6567–6576.
  • Spruill ML, Maletic-Savatic M, Martin H, Li F, Liu X. 2022. Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging. Biochem Pharmacol. 201:115080.
  • Swales JG, Hamm G, Clench MR, Goodwin RJA. 2019. Mass spectrometry imaging and its application in pharmaceutical research and development: a concise review. Int J Mass Spectrom. 437:99–112.
  • Swales JG, Tucker JW, Spreadborough MJ, Iverson SL, Clench MR, Webborn PJH, Goodwin RJA. 2015. Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imaging. Anal Chem. 87(19):10146–10152.
  • Tacar O, Sriamornsak P, Dass CR. 2013. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 65(2):157–170.
  • Takats Z, Strittmatter N, McKenzie JS. 2017. Ambient mass spectrometry in cancer research. In: Advances in cancer research. Amsterdam: Elsevier; p. 231–256.
  • Takáts Z, Wiseman JM, Gologan B, Cooks RG. 2004. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 306(5695):471–473.
  • Thakur A, Tan Z, Kameyama T, El-Khateeb E, Nagpal S, Malone S, Jamwal R, Nwabufo CK. 2021. Bioanalytical strategies in drug discovery and development. Drug Metab Rev. 53(3):434–458. Taylor & Francis.
  • Thavarajah R, Mudimbaimannar V, Rao U, Ranganathan K, Elizabeth J. 2012. Chemical and physical basics of routine formaldehyde fixation. J Oral Maxillofac Pathol. 16(3):400–405.
  • Tortorella S, Tiberi P, Bowman AP, Claes BSR, Ščupáková K, Heeren RMA, Ellis SR, Cruciani G. 2020. LipostarMSI: comprehensive, vendor-neutral software for visualization, data analysis, and automated molecular identification in mass spectrometry imaging. J Am Soc Mass Spectrom. 31(1):155–163.
  • Tuck M, Blanc L, Touti R, Patterson NH, Van Nuffel S, Villette S, Taveau J-C, Römpp A, Brunelle A, Lecomte S, et al. 2021. Multimodal imaging based on vibrational spectroscopies and mass spectrometry imaging applied to biological tissue: a multiscale and multiomics review. Anal Chem. 93(1):445–477.
  • US Food and Drug Administration. 2018. Bioanalytical method validation guidance for industry. Silver Spring (MD): Food and Drug Administration.
  • Verbeeck N, Spraggins JM, Murphy MJM, Wang H, Deutch AY, Caprioli RM, Van de Plas R. 2017. Connecting imaging mass spectrometry and magnetic resonance imaging-based anatomical atlases for automated anatomical interpretation and differential analysis. Biochim Biophys Acta Proteins Proteom. 1865(7):967–977.
  • Wang Y, Chen L. 2020. Lung tissue distribution of drugs as a key factor for COVID-19 treatment. Br J Pharmacol. 177(21):4995–4996.
  • Watrous JD, Dorrestein PC. 2011. Imaging mass spectrometry in microbiology. Nat Rev Microbiol. 9(9):683–694.
  • Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS. 2008. Molecular imaging in drug development. Nat Rev Drug Discov. 7(7):591–607.
  • Wilschefski S, Baxter M. 2019. Inductively coupled plasma mass spectrometry: introduction to analytical aspects. Clin Biochem Rev. 40(3):115–133.
  • Winograd N. 2018. Gas cluster ion beams for secondary ion mass spectrometry. Annu Rev Anal Chem. 11(1):29–48.
  • Xue J, Liu H, Chen S, Xiong C, Zhan L, Sun J, Nie Z. 2018. Mass spectrometry imaging of the in situ drug release from nanocarriers. Sci Adv. 4(10):eaat9039.
  • Zecchi R, Trevisani M, Pittelli M, Pedretti P, Manni ME, Pieraccini G, Pioselli B, Amadei F, Moneti G, Catinella S. 2013. Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach. Eur J Mass Spectrom. 19(6):475–482.
  • Zhang Y, Buchberger A, Muthuvel G, Li L. 2015. Expression and distribution of neuropeptides in the nervous system of the crab Carcinus maenas and their roles in environmental stress. Proteomics. 15(23–24):3969–3979.
  • Zhang Z, Tang W. 2018. Drug metabolism in drug discovery and development. Acta Pharm Sin B. 8(5):721–732.
  • Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, et al. 2020. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 181(5):1016–1035.e19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.